-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Hold on Edwards Lifesciences, Raises Price Target to $81

Benzinga·07/25/2025 18:17:20
Listen to the news
Canaccord Genuity analyst William Plovanic maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $75 to $81.